News
Medesis Pharma Successfully Completes Phase I Clinical Trial of NP01
Medesis Pharma, the French based pharmaceutical company, announces the successful completion of a phase I clinical trial of NP01, a first in class anti-diabetic for the treatment of type 2 diabetes mellitus.
2010-05-31 | Read the full article
SMi 5th Conference on RNAi, siRNA and miRNA – The future of personalised medicine
Medesis Pharma will give a keynote presentation at the SMi 5th Conference on RNAi, siRNA and miRNA.
2010-03-18 | Read the full article
Positive Opinion for Orphan Drug Designation
Medesis Pharma's treatment for Huntington's disease has received a positive opinion for orphan drug designation from the Committee for Ophan Medicinal Products (COMP)
2009-12-03 | Read the full article
